SCHEMBL26215428

SCHEMBL26215428

Nc1c(-c2ccc([N+](=O)[O-])cc2)nsc1C(F)(F)F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCC8 Q09428 1/20 0.47
KCNJ11 Q14654 1/20 0.47
MAPT P10636 4/20 0.43
ALDH1A1 P00352 3/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
PKM P14618 1/20 0.43
MAPK1 P28482 1/20 0.43
HTT P42858 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
GAA P10253 2/20 0.42
MGAM O43451 1/20 0.42
SI P14410 1/20 0.42
MGAM2 Q2M2H8 1/20 0.42
LMNA P02545 1/20 0.42
SRC P12931 1/20 0.39
BRAF P15056 1/20 0.39
KDR P35968 1/20 0.39
GYS1 P13807 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26215431 0.80 ABCC8 (0.44) ABCC8KCNJ11MAPTALDH1A1MEN1
SCHEMBL19643635 0.77 FFAR4 (0.42) ALDH1A1HTTGAAMGAMSI
SCHEMBL10985021 0.74 MAPT (0.49) MAPTALDH1A1MEN1KMT2APKM
SCHEMBL26215430 0.73 AR (0.54) MAPTALDH1A1PKMMAPK1HTT
SCHEMBL17626088 0.72 ABCC8 (0.48) ABCC8KCNJ11MAPTALDH1A1MEN1
SCHEMBL15063946 0.70 KDR (0.53) MAPTALDH1A1MEN1KMT2APKM
SCHEMBL4468508 0.69 ALDH1A1 (0.46) MAPTALDH1A1MEN1KMT2APKM
SCHEMBL8986919 0.69 ALDH1A1 (0.60) MAPTALDH1A1MEN1KMT2AGAA
SCHEMBL26215429 0.68 RAD51 (0.44) ABCC8KCNJ11MAPTALDH1A1MEN1
SCHEMBL18448340 0.67 MAPT (0.53) ABCC8KCNJ11MAPTALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230286904-A1 INHIBITORS OF YAP/TAZ-TEAD ONCOPROTEINS, SYNTHESIS AND USE THEREOF BRIDGENE BIOSCIENCES, INC. 2023-09-14 US disclosed
CN-116490201-A Inhibitors of YAP/TAZ-TEAD tumor proteins, their synthesis and use 布里奇恩生物科学公司 2023-07-25 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230286904-A1 INHIBITORS OF YAP/TAZ-TEAD ONCOPROTEINS, SYNTHESIS AND USE THEREOF TEAD1, TEAD2, TEAD3 ABCC8 4459/4885KCNJ11 4876/4885MAPT 433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.